Enhanced production and gene expression of IL-5 in bronchial asthma: Possible management of atopic diseases with IL-5 specific gene transcription inhibitor

Advances in Experimental Medicine and Biology

Volumn 409, Issue , 1996, Pages 439-450

  Mori, Akio ^a   Suko, Matsunobu ^a   Kaminuma, Osamu ^a   Nishizaki, Yoko ^a   Nagahori, Toshifumi ^a   Mikami, Tadashi ^a   Ohmura, Takeo ^a   Hosino, Akihiko ^a   Asakura, Yumiko ^a   Okudaira, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; OM 01; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ATOPY; CELL CLONE; CONFERENCE PAPER; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 8244239688     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5855-2_64     Document Type: Conference Paper

References (36)

1. Azzawi, M., Bradley, B., Jeffery, P. K., Frew, A. J., Wardlaw, A. J., Knowles, G., Assoufi, B., Collins, J. V., Durham, S., and Kay, A. B. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1410.
2. Dunnill, M. S. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27.
3. Wardlaw, A. J., Dunnette, S., Gleich, G. J., Collins, J. V., and Kay, A. B. 1988. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62.
4. Gleich, G. J., and Adolphson, C. R. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39:177.
5. Jeffery, P. K., Wardlaw, A. J., Nelson, F. C., Collins, J. V., and Kay, A. B. 1989. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am. Rev. Respir. Dis. 140:1745.
6. Kay, A. B. 1992. "Helper" (CD4) T cells and eosinophils in allergy and asthma. Am. Rev. Respir. Dis. 145:822.
7. Kirby, J. G., Hargreave, F. E., Gleich, G. J., and O'Byrne, P. M. 1987. Bronchoalveolar cell profiles of asthmatic and non-asthmatic subjects. Am. Rev. Respir. Dis. 136:379.
8. Dohi, M., Okudaira, H., Sugiyama, H., Tsuramachi, K., Suko, M., Nakagawa, H., and Miyamoto, T. 1990. Bronchial responsiveness to mite allergen in atopic dermatitis without asthma. Int. Arch. Allergy Appl. Immunol. 92:138.
9. Coffman, R. L., Seymour, B. W., Hudak, S., Jackson, J., and Rennick. D. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.
10. De Monchy, J. G., Kauffman, H. F., Venge, P., Koeter, G. H., Jansen, H. M., Sluiter, H. J., and De Vries, K. 1985. Broncho-alveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373.
11. Durham, S. R., and Kay, A. B. 1985. Eosinophils, bronchial hyperreactivity and late asthmatic reactions. Clin. Allergy 40:411.
12. Hamid, Q., Azzawi, M., Sun Ying Moqbel, R., Wardlaw, A. J., Corrigan, C. J., Bradley, B., Durham, S. R., Collins, J. V., Jeffery, P. K., Quint, J., and Kay, A. B. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541.
13. Kaliner, M. 1984. Hypotheses on the contribution of late-phase allergic responses to the understanding and treatment of allergic diseases. J. Allergy Clin. Immunol. 73:311.
14. Okudaira, H., Nogami, M., Matsuzaki, G., Dohi, M., Suko, M., Kasuya, S., and Takatsu, K. 1991. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int. Arch. Allergy Appl. Immunol. 94:171.
15. Nogami, M., Suko, M., Okudaira, H., Miyamoto, T., Shiga, J., Ito, M., and Kasuya, S. 1990. Experimental pulmonary eosinophilia in mice by ascaris suum extract. Am. Rev. Respir. Dis. 141:1289.
16. Corrigan, C. T., and Kay, A. B. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501.
17. Walker, C., Bode, E., Boer, L., Hansel, T. T., Blaser, K. and Virchow, J. C. 1992. Allergic and non-allergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109.
18. Corrigan, C. J., Haczku, A., Gemou-Engesaeth, V., Doi, S., Kikuchi, Y., Takatsu, K., Durham, S. R., and Kay, A. B. 1993. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am. Rev. Respir. Dis. 147:540.
19. Robinson, D., Hamid, Q., Bentley, A., Ying, S., Kay, A. B., and Kurham, S. R. 1993. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313.
20. Huang, S. K., Krishnaswamy, G., Suz, S. N., Marsh, D. G., and Liu, M. 1993. Analysis of cytokine transcripts in the broncho-alveolar lavage cells of patients with asthma. J. Immunol. 150:138A. (AAI meeting, Abstr.)
21. Kay, A. B., Ying, S., Varney, V., Gaga, M., Durham, S. R., Moqbel, R., Wardlaw, A. J., Hamid, Q. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:775-778.
22. Mori, A., Suko, M., Nishizaki, Y., Kaminuma, O., Kobayashi, S., Matsuzaki, G., Yamamoto, K., Ito, K., Tsuruoka, N., and Okudaira, H. 1995. Interleukin-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immnol. 7:449.
23. Okudaira, H., Mori, A., Suko, M., Etoh, T., Nakagawa, H., and Ito, K., 1994. Enhanced production and gene expression of IL-5 in bronchial asthma - management of atopic diseases with agents that down regulate IL-5 gene transcription. ACI News 6:19
24. Mori, A., M. Suko, N. Tsuruoka, T. Etoh, H. Nakagawa, O. Kaminuma, K. Ito, and H. Okudaira. 1994. Atopic diseases and eosinophilic inflammation - Possible management with downregulation of IL-5 gene transcription. Environ. Dermatol. 1:42.
25. Steel, C., and Nutman, T. B. 1993. Regulation of IL-5 in onchocerciasis - a critical role for IL-2. J. Immunol. 150:5511.
26. Minami, Y. Kono, T., Miyazaaki, T., and Taniguti, T. 1993. The IL-2 receptor complex: Its structure, function, and target gene. Annu. Rev. Immunol. 11:245
27. Robinson, D. S., Ying, S., Bentley, A. M., Meng, Q., North, J., Durham, S. R., Kay, A. B. and Hamid, Q. 1993. Relationships among number of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397.
28. Robinson, D., Hamid, Q., Bentley, A., Ying, S., Kay, A. B., Durham, S. R., 1993. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin. Immunol. 92:313.
29. Robinson D. S. Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigen C., Durham S. R., Kay A. B.: Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
30. Broide, D. H., Lots, M., Cuomo, A. J., Coburn, D. A., Federman, E.G., and Wasserman, S. I. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958.
31. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science, 243:355.
32. Durand, D. B., Morgan, M. R., Weiss, A., Crabtree, G. R., 1987. A 257 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promotor in response to signals from the T cell antigen receptor. J. Exp. Med. 165:359.
33. Sigal, N. H., and Dumont, F. J. 1992. Cyclosporin A, FK506 and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519.
34. Schreiber, S. L., and Crabtree, G. R. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136
35. Vacca, A., Felli, M. P., Farina, A. R., Martinotti, S., Maroder, M., Screpanti, I., Meco, D., Petrangeli, E., Frati, L., and Gulino, A. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175:637.
36. Weinberger, C., Hollenberg, S. M., Ong, E. S., Harmon, J. M., and Brower, S. T., Cidlowski, J., Thompson, E. B., Rosenfeld, N. G., and Evans, R. H. 1985. Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228:740.